Analystreport

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com